Aprogen Biologics Inc. (003060.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩1,396 (+0.65%) as of
Key statistics
- Market cap
- 22.70B
- Dividend yield
- 0.00%
- 52-week range
- 1,375.00 – 9,940.03
- Beta
- -0.20
- Revenue (TTM)
- 86.18B
- Profit margin
- -90.85%
- Volume
- 32.41k
About Aprogen Biologics Inc.
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 262
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.